Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Preclinical Investigation of the p53-MDM2 Antagonist Idasanutlin (RG7388) Demonstrates Significant Activity in High Risk Adult Acute Lymphoblastic Leukemia

Hayden L Bell, Mankaran Singh, MSc, Helen J Blair, PhD, Frederik W. van Delft, MD PhD, Anthony V. Moorman, PhD, John Lunec, PhDMRCR(Hon) FRCPath, Julie Irving, PhD

Blood (2020) 136 (Supplement 1): 38.

https://doi.org/10.1182/blood-2020-139536

Published: 2020

Journal Articles

Distinctive Genotypes In Infants With T-Cell Acute Lymphoblastic Leukemia (T-ALL)

Marcela B Mansur, PhD, Frederik W Van Delft, MD PhD, Caroline L Furness, MD, Mariana Emerenciano, PhD, Susan M Colman, Emma Butcher, Helena Kempski, Emmanuelle Clappier, Hélène Cave, PhD, Jean Soulier, MD, PhD, Maria S. Pombo-de-Oliveira, MD, PhD, Mel Greaves, PhD, FRS, Anthony M Ford, PhD

Blood (2013) 122 (21): 1377.

https://doi.org/10.1182/blood.V122.21.1377.1377

Published: 2013

Journal Articles

Clonal Evolution and Sub-Clonal Architecture In Paediatric T-Cell Acute Lymphoblastic Leukaemia (T-ALL)

Caroline L Furness, MD, Marcela B Mansur, PhD, Victoria J Weston, PhD, Frederik W Van Delft, MD PhD, Christine J Harrison, PhD, Lyndal Kearney, PhD, Anthony M Ford, PhD, Pamela R Kearns, MBChB, PhD, FRCPCH, Nicola E Potter, PhD, Jean Soulier, MD, PhD, Adolfo A. Ferrando, MD, PhD, Mel Greaves, PhD, FRS

Blood (2013) 122 (21): 1366.

https://doi.org/10.1182/blood.V122.21.1366.1366

Published: 2013

Journal Articles

Familial AML With Germline CEBPA Mutations: Extended Clinical Outcomes and Analysis Of Secondary Mutations Using Whole Exome Sequencing

Kiran Tawana, MD, Aline Renneville, Jun Wang, PhD, Panayiotis Georgiades, Xavier Thomas, MD, Valerie Mialou, MD, Aleksander Savic, MD, Frederik W Van Delft, MD PhD, Jennifer G. Treleaven, MD, Sameena Iqbal, Norio Asou, MD, PhD, Naokuni Uike, MD, Konstanze Döhner, MD, Lars Bullinger, MD, PhD, Matthias Stelljes, MD, Csaba Bödör, PhD, James D. Cavenagh, MD, Doris Steinemann, PhD, Tim Ripperger, MD, Brigitte Schlegelberger, MD, PhD, Peter Vandenberghe, MD, PhD, Anne Uyttebroeck, MD, Josep F. Nomdedeu, MD, Henrik Hjorth-Hansen, MD, PhD, Rosemary E Gale, PhD, Cynthia L. Toze, MD, FRCP(C), Michael J. Barnett, BMBS, FRCPC, FRCP, FRCPath, Marianna Zombori, MD, Krisztian Kallay, MD, Jiri Pavlu, MD, Pim Mutsaers, MD, Fred H Menko, MD, Angela Thomas, PhD, FRCPath, FRCP, MB, BS, Christine Wright, MD, Jessica Okosun, MD, Chey Loveday, PhD, Pierre Fenaux, MD, PhD, Hamish Scott, PhD, Claude Preudhomme, Claude Chelala, PhD, Alison Male, MD, Carolyn J. Owen, MD, FRCPC, Matthew Smith, MD, PhD, Jude Fitzgibbon, PhD

Blood (2013) 122 (21): 740.

https://doi.org/10.1182/blood.V122.21.740.740

Published: 2013

Journal Articles

Genetics of Teenage and Young Adult Acute Lymphoblastic T-Cell Leukaemia.

Frederik W Van Delft, MD PhD, Caroline L Furness, MA, MBBChir, MRCPCH, Marcela B Mansur, PhD, Lynne Minto, Julie Irving, Sameena Iqbal, Elda Noronha, Sue Colman, John G Gribben, Maria S Pombo-de-Oliveira, Mel Greaves, MD, PhD

Blood (2012) 120 (21): 2521.

https://doi.org/10.1182/blood.V120.21.2521.2521

Published: 2012

Journal Articles

Epigenetic Changes in CEBPα Gene and Xenotransplantation Model of B Cell Precursor Acute Lymphoblastic Leukemia Switching to Monocytoid Lineage During the Early Phase of the Treatment

Blood (2012) 120 (21): 876.

https://doi.org/10.1182/blood.V120.21.876.876

Published: 2012

Journal Articles

Sub-Clonal Genetic Heterogeneity in BCR-ABL1 Positive Acute Lymphoblastic Leukaemia

Maria-Jose Carnicer, PhD, Frederik W van Delft, MD, PhD, Lyndal Kearney, PhD, Mel Greaves, FRS

Blood (2011) 118 (21): 1348.

https://doi.org/10.1182/blood.V118.21.1348.1348

Published: 2011

NARROW

Preclinical Investigation of the p53-MDM2 Antagonist Idasanutlin (RG7388) Demonstrates Significant Activity in High Risk Adult Acute Lymphoblastic Leukemia

Distinctive Genotypes In Infants With T-Cell Acute Lymphoblastic Leukemia (T-ALL)

Clonal Evolution and Sub-Clonal Architecture In Paediatric T-Cell Acute Lymphoblastic Leukaemia (T-ALL)

Familial AML With Germline CEBPA Mutations: Extended Clinical Outcomes and Analysis Of Secondary Mutations Using Whole Exome Sequencing

Genetics of Teenage and Young Adult Acute Lymphoblastic T-Cell Leukaemia.

Epigenetic Changes in CEBPα Gene and Xenotransplantation Model of B Cell Precursor Acute Lymphoblastic Leukemia Switching to Monocytoid Lineage During the Early Phase of the Treatment

Sub-Clonal Genetic Heterogeneity in BCR-ABL1 Positive Acute Lymphoblastic Leukaemia

Email alerts

ASH Publications

American Society of Hematology

Preclinical Investigation of the p53-MDM2 Antagonist Idasanutlin (RG7388) Demonstrates Significant Activity in High Risk Adult Acute Lymphoblastic Leukemia

Distinctive Genotypes In Infants With T-Cell Acute Lymphoblastic Leukemia (T-ALL)

Clonal Evolution and Sub-Clonal Architecture In Paediatric T-Cell Acute Lymphoblastic Leukaemia (T-ALL)

Familial AML With Germline CEBPA Mutations: Extended Clinical Outcomes and Analysis Of Secondary Mutations Using Whole Exome Sequencing

Genetics of Teenage and Young Adult Acute Lymphoblastic T-Cell Leukaemia.

Epigenetic Changes in CEBPα Gene and Xenotransplantation Model of B Cell Precursor Acute Lymphoblastic Leukemia Switching to Monocytoid Lineage During the Early Phase of the Treatment

Sub-Clonal Genetic Heterogeneity in BCR-ABL1 Positive Acute Lymphoblastic Leukaemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only